Top Markets
Coin of the day
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Classifica tra le azioni #24699
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Prezzo delle azioni
$0.95011029
Ultima sincronizzazione: 2023-06-28
Capitalizzazione di mercato
$57.72M
Variazione (1 giorno)
8.53%
Variazione (1 anno)
0.00%
Paese
FR
Scambia ERYTECH Pharma S.A. (ERYP)

Categoria

Storico del prezzo dell'azione per ERYTECH Pharma S.A. (ERYP)
Prezzo di chiusura più alto: $0.90 il 2023-06-01

Prezzo di chiusura più basso: $14.08 il 2013-05-01
Storico del prezzo dell'azione di ERYTECH Pharma S.A. dal 2013 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 73.43%
2022 -78.67%
2021 -73.09%
2020 82.31%
2019 -31.19%
2018 -67.04%
2017 59.44%
2016 -51.05%
2015 -15.86%
2014 158.90%
2013 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$549.19 38.17%
US
$1.05K 58.07%
NL
$148.12 464.91%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH